John Ransom
Stock Analyst at Raymond James
(4.50)
# 321
Out of 4,761 analysts
228
Total ratings
63.64%
Success rate
14.78%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Reiterates: Strong Buy | $415 → $360 | $299.81 | +20.08% | 17 | Jan 31, 2025 | |
| ACCD Accolade | Downgrades: Market Perform | n/a | $6.93 | - | 4 | Jan 9, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $316.42 | - | 21 | Nov 22, 2024 | |
| THC Tenet Healthcare | Downgrades: Outperform | $195 | $129.60 | +50.46% | 17 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $3.51 | - | 8 | Nov 22, 2024 | |
| SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $78.91 | +7.72% | 12 | Nov 1, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.81 | +107.90% | 2 | May 16, 2024 | |
| RDNT RadNet | Maintains: Outperform | $50 → $60 | $59.47 | +0.89% | 10 | May 10, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $97.53 | -2.59% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $10.16 | - | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $90.44 | - | 14 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $255.91 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.82 | +34.95% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $28.22 | +6.31% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $13.18 | -8.95% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $63.48 | +33.90% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $109.23 | -3.87% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $5.33 | +87.79% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.23 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.23 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.61 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $630 | $466.42 | +35.07% | 12 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $39.65 | +152.21% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $32.95 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $32.88 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $142.40 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $25.31 | - | 2 | Aug 9, 2017 |
The Cigna Group
Jan 31, 2025
Reiterates: Strong Buy
Price Target: $415 → $360
Current: $299.81
Upside: +20.08%
Accolade
Jan 9, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $6.93
Upside: -
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $316.42
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $129.60
Upside: +50.46%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.51
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $78.91
Upside: +7.72%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.81
Upside: +107.90%
RadNet
May 10, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $59.47
Upside: +0.89%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $97.53
Upside: -2.59%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $10.16
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $90.44
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $255.91
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $14.82
Upside: +34.95%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $28.22
Upside: +6.31%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $13.18
Upside: -8.95%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $63.48
Upside: +33.90%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $109.23
Upside: -3.87%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $5.33
Upside: +87.79%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.23
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.23
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.61
Upside: -
Apr 17, 2023
Maintains: Strong Buy
Price Target: $630
Current: $466.42
Upside: +35.07%
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $39.65
Upside: +152.21%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $32.95
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $32.88
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $142.40
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $25.31
Upside: -